Results 11 to 20 of about 22,180 (202)
Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials. [PDF]
PLoS ONE, 2013 ObjectiveTo compare the safety and efficacy of adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia.MethodsPopulationadult patients presenting with antipsychotic-induced hyperprolactinemia diagnosed by prolactin level with ...
Xianbin Li, Yilang Tang, Chuanyue Wang
doaj +1 more source
Aripiprazole salts. II. Aripiprazole perchlorate
Acta Crystallographica Section C Crystal Structure Communications, 2012 The molecular structure of aripiprazole perchlorate (systematic name: 4-(2,3-dichlorophenyl)-1-{4-[(2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy]butyl}piperazin-1-ium perchlorate), C23H28Cl2N3O2+·ClO4−, does not differ substantially from the recently published structure of aripiprazole nitrate [Freire, Polla & Baggio (2012).Acta Cryst.C68, o170–o173].
Freire Espeleta, Eleonora +2 more
openaire +3 more sources
Neuromodulation: Technology at the Neural Interface, EarlyView., 2021 Abstract Objectives Obsessive–compulsive disorder (OCD) is a psychiatric disorder with alterations of cortico‐striato‐thalamo‐cortical loops and impaired performance monitoring. Electrophysiological markers such as conflict‐related medial frontal theta (MFT) and error‐related negativity (ERN) may be altered by clinically effective deep brain ...
Elena Sildatke +9 more
wiley +1 more source
Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan
Therapeutic Advances in Psychopharmacology, 2022 Background: Aripiprazole is a third-generation antipsychotic agent with acceptable efficacy and a good safety profile. Previous studies have indicated the therapeutic serum concentration of aripiprazole to be 100 to 350 ng/ml; however, most of these ...
Yun Tien +3 more
doaj +1 more source
Aripiprazole salts. I. Aripiprazole nitrate
Acta Crystallographica Section C Crystal Structure Communications, 2012 The crystal structure of aripiprazole nitrate (systematic name: 4-(2,3-dichlorophenyl)-1-{4-[(2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy]butyl}piperazin-1-ium nitrate), C23H28Cl2N3O2+·NO3−or AripH+·NO3−, is presented and the molecule compared with the aripiprazole molecules reported so far in the literature. Bond distances and angles appear very similar,
Freire Espeleta, Eleonora +2 more
openaire +3 more sources
Pharmacology Research & Perspectives, 2022 Drug repositioning is an alternative process for drug development in cancer. Specifically, it is a strategy for the discovery of new antitumor drugs by screening previously approved clinical drugs.
Hyeon‐Jeong Jeong +6 more
doaj +1 more source
FEBS Open Bio, 2019 Drug repositioning has garnered attention as an alternative strategy to the discovery and development of novel anticancer drug candidates. In this study, we screened 321 FDA‐approved drugs against nonirradiated and irradiated MCF‐7 cells, revealing that ...
Hyounji Lee +3 more
doaj +1 more source
Journal of Pharmacological Sciences, 2008 Aripiprazole, an atypical antipsychotic drug, is a D2dopamine–receptor partial agonist, but also has affinity to several serotonin receptors (5-HT1A,2A,2C,7).
Shuntaro Kohnomi +3 more
doaj +1 more source
Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats. [PDF]
PLoS ONE, 2015 Aripiprazole is a wide-used antipsychotic drug with therapeutic effects on both positive and negative symptoms of schizophrenia, and reduced side-effects.
Bo Pan +4 more
doaj +1 more source
Journal of Experimental Neuroscience, 2015 Aripiprazole is a third-generation atypical antipsychotic and a dopamine D 2 receptor partial agonist. In the present study, we investigated whether a single administration of aripiprazole to mice, either as a pretreatment or as a posttreatment, would ...
Nobue Kitanaka +6 more
doaj +1 more source